Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms
Interventions: DRUG: OGX-427|DRUG: Docetaxel
Sponsor: Achieve Life Sciences